Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis

CONTEXT: The ACTIVE study demonstrated the antifracture efficacy of abaloparatide in postmenopausal women with osteoporosis. ACTIVExtend demonstrated sustained fracture risk reduction with alendronate in abaloparatide-treated participants from ACTIVE. A direct comparison of the efficacy of abalopara...

Descripción completa

Detalles Bibliográficos
Autores principales: Leder, Benjamin Z, Mitlak, Bruce, Hu, Ming-yi, Hattersley, Gary, Bockman, Richard S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112966/
https://www.ncbi.nlm.nih.gov/pubmed/31674644
http://dx.doi.org/10.1210/clinem/dgz162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112966/
https://www.ncbi.nlm.nih.gov/pubmed/31674644
http://dx.doi.org/10.1210/clinem/dgz162

Ejemplares similares